Stem cell firm's Fox cash for Parkinson's R&D (research & development)
This article was originally published in Clinica
Executive Summary
An Israel-based stem cell research company has been awarded $660,000 to significantly advance its research into a treatment for Parkinson's disease using neural cells derived from human embryonic stem cells (hESs).